Efalizumab (CAT#: TP-090CL)
Humanized IgG1 kappa isotype monoclonal antibody that binds to human CD11a. Efalizumab has a molecular weight of approximately 150 kilodaltons and is produced in a Chinese hamster ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Specifications
- Type
- Biotech
- Trade name
- Raptiva
- UNII
- XX2MN88N5D
Target
- Function
- Humanized mAb directed against cD11a
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TP-090CL. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: Neut, ELISA, Inhib, ICC, WB
Application: FC, FRET, Internalization
Application: ELISA, FC, Inhib, FuncS
Application: Neut, IHC, Activ, FuncS, IF, ELISA
Application: ELISA, Neut, FuncS
Application: ELISA, FuncS
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.